Translation/Outcomes

Aagamiseq Technologies is a deep-tech startup developing next-generation diagnostic platforms based on solid-state nanopore technology. Our mission is to simplify molecular diagnostics by replacing complex, capital-intensive instrumentation with compact, semiconductor-based sensing systems.

By directly measuring ionic current signals at the single-molecule level, our technology enables label-free detection and differentiation of nucleic acid sequences, significantly reducing instrument cost, operational complexity, and time-to-result. This approach has the potential to lower diagnostic capital expenditure by up to 50×, while maintaining high analytical sensitivity.

We are building an integrated ecosystem that combines custom nanopore sensors, electronics, and signal-analysis software, aimed at decentralizing advanced molecular testing from centralized labs to local and resource-constrained settings.

Our long-term vision is to enable affordable, robust, and scalable diagnostic solutions for applications such as cancer screening and prognosis, bridging the gap between cutting-edge physics, engineering, and real-world clinical needs.